top of page

Stifel's Tim Opler shares feedback from SF Healthcare Week and thoughts on biotech's year ahead from a banking perspective

Tim Opler discusses the M&A environment, IPO windown, PIPE and crossover financings, and more.




Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page